Trader consensus prices "No" at 84% for a new WHO-designated COVID variant of concern before 2027, driven by the absence of any recent SARS-CoV-2 strain meeting strict VOC criteria like significantly higher transmissibility, severity, or vaccine evasion. The emerging BA.3.2 "Cicada" subvariant, spreading across 30+ U.S. states and Europe since late March 2026, shows immune escape potential but no evidence of increased hospitalizations or deaths, per CDC and ECDC updates through April 24. Broad population immunity from updated 2025-2026 vaccines and prior infections, combined with Omicron's dominance as an endemic baseline, underpins this positioning, though global surveillance continues amid summer case upticks.
Resumen experimental generado por IA con datos de Polymarket. Esto no es asesoramiento de trading y no influye en cómo se resuelve este mercado. · ActualizadoSí
$237,430 Vol.
$237,430 Vol.
31 dic 2026
Sí
$237,430 Vol.
$237,430 Vol.
31 dic 2026
This market will resolve to "Yes" if the CDC identifies a new COVID variant of concern between December 1, 2025, and December 31, 2026, 11:59PM ET. Otherwise this market will resolve to "No".
The CDC's variant classification scheme can be found here: https://stacks.cdc.gov/view/cdc/107682.
The resolution source for this market will be official information from the CDC.Trader consensus prices "No" at 84% for a new WHO-designated COVID variant of concern before 2027, driven by the absence of any recent SARS-CoV-2 strain meeting strict VOC criteria like significantly higher transmissibility, severity, or vaccine evasion. The emerging BA.3.2 "Cicada" subvariant, spreading across 30+ U.S. states and Europe since late March 2026, shows immune escape potential but no evidence of increased hospitalizations or deaths, per CDC and ECDC updates through April 24. Broad population immunity from updated 2025-2026 vaccines and prior infections, combined with Omicron's dominance as an endemic baseline, underpins this positioning, though global surveillance continues amid summer case upticks.
This market will resolve to "Yes" if the CDC identifies a new COVID variant of concern between December 1, 2025, and December 31, 2026, 11:59PM ET. Otherwise this market will resolve to "No".
The CDC's variant classification scheme can be found here: https://stacks.cdc.gov/view/cdc/107682.
The resolution source for this market will be official information from the CDC.
The CDC's variant classification scheme can be found here: https://stacks.cdc.gov/view/cdc/107682.
The resolution source for this market will be official information from the CDC.
Mercado abierto: Dec 1, 2025, 4:49 PM ET
Volumen
$237,430Fecha de finalización
31 dic 2026Mercado abierto
Dec 1, 2025, 4:49 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if the CDC identifies a new COVID variant of concern between December 1, 2025, and December 31, 2026, 11:59PM ET. Otherwise this market will resolve to "No".
The CDC's variant classification scheme can be found here: https://stacks.cdc.gov/view/cdc/107682.
The resolution source for this market will be official information from the CDC.Trader consensus prices "No" at 84% for a new WHO-designated COVID variant of concern before 2027, driven by the absence of any recent SARS-CoV-2 strain meeting strict VOC criteria like significantly higher transmissibility, severity, or vaccine evasion. The emerging BA.3.2 "Cicada" subvariant, spreading across 30+ U.S. states and Europe since late March 2026, shows immune escape potential but no evidence of increased hospitalizations or deaths, per CDC and ECDC updates through April 24. Broad population immunity from updated 2025-2026 vaccines and prior infections, combined with Omicron's dominance as an endemic baseline, underpins this positioning, though global surveillance continues amid summer case upticks.
This market will resolve to "Yes" if the CDC identifies a new COVID variant of concern between December 1, 2025, and December 31, 2026, 11:59PM ET. Otherwise this market will resolve to "No".
The CDC's variant classification scheme can be found here: https://stacks.cdc.gov/view/cdc/107682.
The resolution source for this market will be official information from the CDC.
The CDC's variant classification scheme can be found here: https://stacks.cdc.gov/view/cdc/107682.
The resolution source for this market will be official information from the CDC.
Volumen
$237,586Fecha de finalización
31 dic 2026Mercado abierto
Dec 1, 2025, 4:49 PM ETResolver
0x65070BE91...Trader consensus prices "No" at 84% for a new WHO-designated COVID variant of concern before 2027, driven by the absence of any recent SARS-CoV-2 strain meeting strict VOC criteria like significantly higher transmissibility, severity, or vaccine evasion. The emerging BA.3.2 "Cicada" subvariant, spreading across 30+ U.S. states and Europe since late March 2026, shows immune escape potential but no evidence of increased hospitalizations or deaths, per CDC and ECDC updates through April 24. Broad population immunity from updated 2025-2026 vaccines and prior infections, combined with Omicron's dominance as an endemic baseline, underpins this positioning, though global surveillance continues amid summer case upticks.
Resumen experimental generado por IA con datos de Polymarket. Esto no es asesoramiento de trading y no influye en cómo se resuelve este mercado. · Actualizado
Cuidado con los enlaces externos.
Cuidado con los enlaces externos.
Preguntas frecuentes